Agencies and Organizations Involved with International Health - PowerPoint PPT Presentation

1 / 34
About This Presentation
Title:

Agencies and Organizations Involved with International Health

Description:

... and specificity of palpation are low, particularly in ... Palpation ... Correspondence Between U/S and Palpation - Nepal. PVP = 28.3% PVN = 83.2 ... – PowerPoint PPT presentation

Number of Views:1231
Avg rating:3.0/5.0
Slides: 35
Provided by: gorpakun
Category:

less

Transcript and Presenter's Notes

Title: Agencies and Organizations Involved with International Health


1
Iodine Deficiency Disorders
NUTR 600/ HSERV 590
2
Iodine Deficiency Disorders
  • The single most preventable cause of mental
    retardation and brain damage in the world
  • Control programs are in place in most countries
    of the world, primarily through salt iodization
  • Scientific data are required to demonstrate that
    adequate amounts of iodine are reaching the
    target population and having an impact.
  • However, there has been a lack of clarity in
    indicators (and criteria) for tracking progress

3
Iodine Deficiency Disorders
  • World Health Assembly (1990) adopted the goal of
    the elimination of IDD as a public health problem
    by the year 2000
  • Progress towards the elimination of IDD can only
    be demonstrated if it is measured
  • This requires the selection of appropriate
    indicators of both process and impact

4
Causes of Iodine Deficiency
Snow
Atmosphere
Rain
Iodine is not available in the soil, since it is
washed away by rain and snow, mostly in mountain
areas and plains
Lake
River
Sea
Iodine
5
Daily Iodine Requirements
Just a teaspoon in a lifetime
Daily physiological requirements for adults
100-150 ?g Assumed daily per capita salt
consumption 10 grams Fortification level of
elemental iodine 15 ppm
6
Spectrum of Iodine Deficiency Disorders
Fetus Abortion Still Birth Congenital
Anomalies Increased Perinatal and Infant
Mortality Cretinism (Neurological and
Myxedematous)
  • Neonatal Neonatal Hypothyroidism

Childhood Impaired mental and physical
development
Adult Complications of Goiter Iodine-induced
hyperthyroidism (IIH)
All ages Goiter Hypothyroidism
NUTR 600/ HSERV 590
7
Population with Iodine Deficiency
At risk of mental impairment 1.6 billion
WHO (1999)
8
Population with Iodine Deficiency
Goitre 655 million
At risk of mental impairment 1.6 billion
WHO (1999)
9
Population with Iodine Deficiency
Brain damage 26 million
Goitre 655 million
At risk of mental impairment 1.6 billion
WHO (1999)
10
Population with Iodine Deficiency
Cretinism 6 million
Brain damage 26 million
Goitre 655 million
At risk of mental impairment 1.6 billion
WHO (1999)
11
Population with Iodine Deficiency
Cretinism
Brain damage
Goitre
At risk of mental impairment 1.6 billion
WHO (1999)
12
Population with Iodine Deficiency
Cretinism
Brain damage
Goitre
At risk of mental impairment 1.6 billion
WHO (1999)
13
Function of the Thyroid Hormones
Brain
Pituitary
TSH
Thyroid gland
Thyroid
hormones
Muscle
Heart
Kidneys
Liver
14
Enlargement of thyroid gland
15
Indicators of IDD in a Population
  • Process of adequately iodized salt at
    production level
  • of adequately iodized salt at household level
  • of iodized salt at household level
  • Impact Goiter
  • Urinary iodine excretion (UIE)
  • Thyroid hormones

16
Indicators of IDD - Process
  • Salt iodine levels
  • Two methods
  • Rapid test kits (semi-quantitative)
  • Titration
  • Salt monitoring systems
  • Ensure adequate iodine levels at all points of
    distribution from Production to Household
  • Where problems are identified, take corrective
    action

17
Indicators of IDD - Impact
  • Goiter
  • Total goiter prevalence
  • Grade 0 No palpable or visible goiter
  • Grade 1 Palpable goiter
  • Grade 2 Visible goiter
  • Urinary iodine excretion (UIE)
  • Best marker of recent dietary intake of iodine
  • Most iodine absorbed in the body eventually
    appears in urine

18
Indicators of IDD - TGR
  • Total Goiter prevalence
  • WHO, UNICEF, ICCIDD (2001)
  • Prevalence Significance of Public Health Problem
  • lt 5 No IDD
  • 5-19.9 Mild IDD
  • 20-29.9 Moderate IDD
  • ? 30 Severe IDD

19
Iodine Deficiency - Goiter
Visible goiters pretty easy to diagnose
20
Iodine Deficiency - Goiter
Palpable goiters are much more problematic
  • WHO revised criteria for palpable goiter
  • 1960 lobes larger than ends of thumbs
  • 1994 an enlarged thyroid that is palpable, but
    not visible
  • In Tanzania, change in clinical definition led to
    a 25 increase in the prevalence of palpable
    goiter
  • Comparability may become problematic and lead to
    smaller decreases over time, or actual increase
    in goiter in spite of IDD control efforts

21
Assessment of Enlarged Thyroid
  • Clinical observation of the thyroid by palpation
    has been the conventional method to assess goiter
  • Ultrasound (U/S) has become more widely used to
    provide a more precise measurement of thyroid
    volume.
  • U/S is particularly important when the prevalence
    of visible goiters is low
  • Problem with U/S is the lack of normative
    reference data (from iodine replete population)

22
Inter-observer variation in palpation
  • The sensitivity and specificity of palpation are
    low, particularly in grades 0 and 1 due to high
    inter-observer variation.
  • In studies of trained endocrinologists, there is
    as much as 30-40 disagreement in the
    classification with ? lt 0.40

23
Correspondence Between U/S and Palpation - Nepal
  • As part of National MN Survey
  • Sub-sample of 403 SAC (8-10 years of age)
  • U/S measured by single trained examiner (gold
    standard) using a SonoAce 600 portable U/S
    machine
  • Palpation performed by field teams
  • Thyroid volume calculated based on measurements
    of the width, depth and length using standard
    formula
  • Thyroid volume compared to standard thyroid
    volume-for-age values and dichotomised normal
    (lt 97th centile) and enlarged (gt 97th centile)

24
Correspondence Between U/S and Palpation - Nepal
PVP 28.3 PVN 83.2 Se 69.1 Sp 46.6
Gorstein (2001)
25
Indicators of IDD - UIE
  • Population IDD Status
  • WHO, UNICEF, ICCIDD (2001)
  • Median value Iodine Status
  • lt 20 ?g/l Severe iodine deficiency
  • 20-49 Moderate iodine deficiency
  • 50-99 Mild iodine deficiency
  • 100-199 Ideal iodine intake
  • 200-299 More than adequate intake (may pose
    risk of IIH)
  • ? 300 Excessive iodine intake
  • In populations with longstanding iodine
    deficiency and rapid improvement in iodine
    intake, median values above 200 ?g/l are not
    recommended

26
IDD IndicatorsDepends on the status of control
program
  • It is now accepted that thyroid volume is less
    useful in assessing current IDD status during
    implementation of USI and soon after achieving
    USI
  • Prior to any intervention, the prevalence of low
    UI and goiter will be in agreement with each
    other indicating IDD
  • Once USI is phased in (over months or years), the
    prevalence of low UI will fall faster than the
    prevalence of goiter

27
Appropriateness of IDD IndicatorsDepends on
control program status
28
Changes in IDD IndicatorsChina clinical trial,
Jiangsu Province
  • IDD endemic area
  • Households provided with iodised salt at 25 ppm
  • Baseline and follow-up at 6,9,12 and 18 months
    after initiation of intervention
  • At baseline, the severity of IDD was mild (based
    on UIE) and moderate (based on TGR and U/S)
  • After six months, UIE had increased to adequate
    levels, while thyroid size measures still
    indicated moderate IDD
  • After 18 months, all three measures indicated
    adequate iodine status

Sullivan, et. al., 2001
29
IDD IndicatorsDepends on the status of control
program
  • Just as it takes years for goiter to develop in
    school children, it takes years for the thyroid
    to return to normal size after iodine
    sufficiency is achieved
  • The amount of time it takes for the UI and
    thyroid size to be in agreement will depend on
    the severity of IDD at baseline and the length of
    time it takes to phase in the USI program

30
Correspondence between Indicators
UNICEF, 1997
31
Criteria for IDD Elimination - 2000
WHO, UNICEF ICCIDD (2001)
32
Implications
  • Urinary iodine is responsive to improvements in
    iodine intake
  • However, the criteria for adequacy of USI
    programs may be too rigid and does not take into
    account differences in salt consumption
  • In many developing countries (including Nepal),
    more than 10 grams of salt are consumed per day
    and therefore lower levels of iodine in salt
    (ppm) may be necessary

33
Control of IDD through Universal Salt Iodisation
(USI)
  • Today
  • Some 70 per cent of households in the developing
    world are using iodized salt, compared to less
    than 20 per cent at the beginning of the decade.
  • As a result, 91 million newborns are protected
    yearly from significant loss in learning ability
  • Unfinished Business
  • There are still 35 countries where less than half
    the households consume iodized salt

34
Coverage of Iodized Salt by Region
Source UNICEF (2002)
35
Levels of Iodized Salt Coverage
90 or more
50 to 89

Less than 50
Source UNICEF (2002)
No recent data
36
Major Increases in Iodized Salt Coverage
Source UNICEF (2004)
37
41 Million Newborns Still Unprotected from
Learning Disabilities
Source UNICEF (2002)
Write a Comment
User Comments (0)
About PowerShow.com